{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:38:28Z","timestamp":1784263108518,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Chemical Neuroanatomy"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.jchemneu.2008.01.001","type":"journal-article","created":{"date-parts":[[2008,1,20]],"date-time":"2008-01-20T01:10:09Z","timestamp":1200791409000},"page":"268-274","source":"Crossref","is-referenced-by-count":5,"title":["Intact coupling of M1 receptors and preserved M2 and M4 receptors in the cortex in progressive supranuclear palsy: Contrast with other dementias"],"prefix":"10.1016","volume":"35","author":[{"given":"Naomi M.","family":"Warren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Piggott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine K.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Burn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchemneu.2008.01.001_bib1","first-page":"191","article-title":"Progressive supranuclear palsy: anatomoclinical and biochemical considerations","volume":"45","author":"Agid","year":"1987","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.jchemneu.2008.01.001_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","article-title":"Parallel organization of functionally segregated circuits linking basal ganglia and cortex","volume":"9","author":"Alexander","year":"1986","journal-title":"Ann. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.jchemneu.2008.01.001_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/jnnp.65.2.155","article-title":"Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study","volume":"65","author":"Asahina","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jchemneu.2008.01.001_bib4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neuron.2006.01.020","article-title":"M1 receptors play a central role in modulating AD-like pathology in transgenic mice","volume":"49","author":"Caccamo","year":"2006","journal-title":"Neuron"},{"issue":"Pt 3","key":"10.1016\/j.jchemneu.2008.01.001_bib5","first-page":"785","article-title":"Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy","volume":"108","author":"D\u2019Antona","year":"1985","journal-title":"Brain"},{"key":"10.1016\/j.jchemneu.2008.01.001_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1034\/j.1600-0404.2001.103002123.x","article-title":"Donepezil in the treatment of progressive supranuclear palsy","volume":"103","author":"Fabbrini","year":"2001","journal-title":"Acta Neurol. Scand."},{"issue":"11\u201312","key":"10.1016\/j.jchemneu.2008.01.001_bib7","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0024-3205(95)00022-X","article-title":"Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: implications for cholinergic-based therapies","volume":"56","author":"Flynn","year":"1995","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.jchemneu.2008.01.001_bib8","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1046\/j.1471-4159.1995.64041888.x","article-title":"Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease","volume":"64","author":"Flynn","year":"1995","journal-title":"J. Neurochem."},{"issue":"2 Pt 1","key":"10.1016\/j.jchemneu.2008.01.001_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1212\/WNL.39.2.257","article-title":"Failure of cholinergic agonist RS-86 to improve cognition and movement in PSP despite effects on sleep","volume":"39","author":"Foster","year":"1989","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jchemneu.2008.01.001_bib10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0893-133X(01)00342-6","article-title":"Effects of age, postmortem delay and storage time on receptor-mediated activation of G-proteins in human brain","volume":"26","author":"Gonzalez-Maeso","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.jchemneu.2008.01.001_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0014-2999(99)00607-X","article-title":"A novel muscarinic M(4) receptor antagonist provides further evidence of an autoreceptor role for the muscarinic M(2) receptor sub-type","volume":"383","author":"Kitaichi","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jchemneu.2008.01.001_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-3-7091-6641-3_6","article-title":"Cognitive disturbances in progressive supranuclear palsy","volume":"42","author":"Litvan","year":"1994","journal-title":"J. Neural Transmission Suppl."},{"issue":"November (5)","key":"10.1016\/j.jchemneu.2008.01.001_bib13","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1212\/WNL.47.5.1184","article-title":"Neuropsychiatric aspects of progressive supranuclear palsy","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jchemneu.2008.01.001_bib14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1212\/WNL.57.3.467","article-title":"Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy","volume":"57","author":"Litvan","year":"2001","journal-title":"Neurology"},{"issue":"4703","key":"10.1016\/j.jchemneu.2008.01.001_bib15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1126\/science.3992249","article-title":"Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation","volume":"228","author":"Mash","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.jchemneu.2008.01.001_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1474-4422(03)00619-7","article-title":"Dementia with Lewy Bodies","volume":"3","author":"McKeith","year":"2004","journal-title":"Lancet Neurol."},{"issue":"3\u20134","key":"10.1016\/j.jchemneu.2008.01.001_bib17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0928-4257(98)80036-3","article-title":"Some cholinergic themes related to Alzheimer's disease: synaptology of the nucleus basalis, location of m2 receptors, interactions with amyloid metabolism, and perturbations of cortical plasticity","volume":"92","author":"Mesulam","year":"1998","journal-title":"J. Physiol. Paris"},{"issue":"2","key":"10.1016\/j.jchemneu.2008.01.001_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/mds.20707","article-title":"Characterizing behavioural and cognitive dysexecutive changes in progressive supranuclear palsy","volume":"21","author":"Millar","year":"2006","journal-title":"Mov. Disorders"},{"issue":"60 (6)","key":"10.1016\/j.jchemneu.2008.01.001_bib19","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1212\/01.WNL.0000052991.70149.68","article-title":"Clinical features and natural history of progressive supranuclear palsy: A clinical cohort study","volume":"25","author":"Nath","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jchemneu.2008.01.001_bib20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.molbrainres.2004.09.012","article-title":"Quantitative analysis of binding parameters of [3H]N-methylscopolamine in central nervous system of muscarinic acetylcholine receptor knockout mice","volume":"133","author":"Oki","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.jchemneu.2008.01.001_bib21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-3-7091-6641-3_19","article-title":"Changes in aminergic receptors in a PSP postmortem brain: correlation with pathological findings","volume":"42","author":"Pascual","year":"1994","journal-title":"J. Neural. Transm. Suppl."},{"issue":"2","key":"10.1016\/j.jchemneu.2008.01.001_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00002093-199040200-00003","article-title":"Cholinergic and dopaminergic activities in senile dementia of Lewy body type","volume":"4","author":"Perry","year":"1990","journal-title":"Alzheimer Dis. Assoc. Disorders"},{"issue":"7","key":"10.1016\/j.jchemneu.2008.01.001_bib23","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/00001756-199403000-00002","article-title":"Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease","volume":"5","author":"Perry","year":"1994","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.jchemneu.2008.01.001_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0891-0618(02)00066-2","article-title":"Comparative distribution of binding of the muscarinic receptor ligands pirenzepine, AF-DX 384, (R,R)-I-QNB and (R,S)-I-QNB to human brain","volume":"24","author":"Piggott","year":"2002","journal-title":"J. Chem. Neuroanat."},{"issue":"9","key":"10.1016\/j.jchemneu.2008.01.001_bib25","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1212\/WNL.36.9.1179","article-title":"Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease","volume":"36","author":"Pillon","year":"1986","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jchemneu.2008.01.001_bib26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/(SICI)1098-2396(199708)26:4<341::AID-SYN2>3.0.CO;2-6","article-title":"Autoradiographic distribution of M1, M2, M3, and M4 muscarinic receptor subtypes in Alzheimer's disease","volume":"26","author":"Rodriguez-Puertas","year":"1997","journal-title":"Synapse"},{"issue":"5","key":"10.1016\/j.jchemneu.2008.01.001_bib27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/ana.410180503","article-title":"Dopaminergic and cholinergic lesions in progressive supranuclear palsy","volume":"18","author":"Ruberg","year":"1985","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jchemneu.2008.01.001_bib28","first-page":"142","article-title":"Enhancement of glycine release from human brain cortex synaptosomes by acetylcholine acting at M4 muscarinic receptors","volume":"266","author":"Russo","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jchemneu.2008.01.001_bib29","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1474-4422(03)00502-7","article-title":"Treatment of Alzheimer's disease:current status and new perspectives","volume":"2","author":"Scarpini","year":"2004","journal-title":"Lancet Neurol."},{"issue":"9192","key":"10.1016\/j.jchemneu.2008.01.001_bib30","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","article-title":"Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study","volume":"354","author":"Schrag","year":"1999","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jchemneu.2008.01.001_bib31","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/mds.10583","article-title":"Health-related quality of life in patients with progressive supranuclear palsy","volume":"18","author":"Schrag","year":"2003","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.jchemneu.2008.01.001_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/jnnp.67.2.209","article-title":"Alterations of muscarinic acetylcholine receptor subtypes in diffuse lewy body disease: relation to Alzheimer's disease","volume":"67","author":"Shiozaki","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jchemneu.2008.01.001_bib33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0304-3940(87)90135-2","article-title":"Guanine nucleotide modulation of muscarinic cholinergic receptor binding in postmortem human brain\u2014a preliminary study in Alzheimer's disease","volume":"82","author":"Smith","year":"1987","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jchemneu.2008.01.001_bib34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","article-title":"Progressive Supranuclear Palsy. A heterogenous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia","volume":"10","author":"Steele","year":"1964","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.jchemneu.2008.01.001_bib35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbr.2005.02.019","article-title":"Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies","volume":"161","author":"Teaktong","year":"2005","journal-title":"Behav. Brain Res."},{"issue":"10","key":"10.1016\/j.jchemneu.2008.01.001_bib36","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archpsyc.59.10.946","article-title":"Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease","volume":"59","author":"Tiraboschi","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"issue":"9","key":"10.1016\/j.jchemneu.2008.01.001_bib37","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.neurobiolaging.2005.07.010","article-title":"Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease","volume":"27","author":"Tsang","year":"2006","journal-title":"Neurobiol. Aging"},{"issue":"7","key":"10.1016\/j.jchemneu.2008.01.001_bib38","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/sj.mp.4001270","article-title":"Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2\/M4 muscarinic receptor knockout mice","volume":"8","author":"Tzavara","year":"2003","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.jchemneu.2008.01.001_bib39","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/cercor\/2.6.526","article-title":"Reorganization of cingulate cortex in Alzheimer's disease: neuron loss, neuritic plaques, and muscarinic receptor binding","volume":"2","author":"Vogt","year":"1992","journal-title":"Cereb. Cortex"},{"issue":"1","key":"10.1016\/j.jchemneu.2008.01.001_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1440-1789.2003.00543.x","article-title":"Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration","volume":"24","author":"Wakabayashi","year":"2004","journal-title":"Neuropathology"},{"issue":"1","key":"10.1016\/j.jchemneu.2008.01.001_bib41","first-page":"16","article-title":"Progressive supranuclear palsy","volume":"7","author":"Warren","year":"2007","journal-title":"Practical Neurol."},{"issue":"6","key":"10.1016\/j.jchemneu.2008.01.001_bib42","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/jnnp.2006.099937","article-title":"The basal ganglia cholinergic neurochemistry of progressive supranuclear palsy and other neurodegenerative diseases","volume":"78","author":"Warren","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"11","key":"10.1016\/j.jchemneu.2008.01.001_bib43","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/mds.21573","article-title":"Basal ganglia cholinergic and dopaminergic function in progressive supranuclear palsy","volume":"22","author":"Warren","year":"2007","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.jchemneu.2008.01.001_bib44","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/nen.0b013e318053db64","article-title":"Muscarinic receptors in the thalamus in progressive supranuclear palsy and other neurodegenerative disorders","volume":"66","author":"Warren","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"7","key":"10.1016\/j.jchemneu.2008.01.001_bib45","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archneur.1988.00520310028012","article-title":"Reductions in acetylcholine and nicotine binding in several degenerative diseases","volume":"45","author":"Whitehouse","year":"1988","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.jchemneu.2008.01.001_bib46","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1523\/JNEUROSCI.22-05-01709.2002","article-title":"Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice","volume":"22","author":"Zhang","year":"2002","journal-title":"J. Neurosci."}],"container-title":["Journal of Chemical Neuroanatomy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891061808000045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891061808000045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T02:35:31Z","timestamp":1557196531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891061808000045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0891061808000045"],"URL":"https:\/\/doi.org\/10.1016\/j.jchemneu.2008.01.001","relation":{},"ISSN":["0891-0618"],"issn-type":[{"value":"0891-0618","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}